Next Article in Journal
Lymphadenitis/Reactive-Hyperplasia, Mimickers of Lymphomas, Low-Grade B-Cell Lymphomas, and Hodgkin Lymphoma
Previous Article in Journal
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
 
 
Article

Article Versions Notes

Hemato 2024, 5(3), 340-349; https://doi.org/10.3390/hemato5030025
Action Date Notes Link
article xml file uploaded 14 September 2024 12:04 CEST Original file -
article xml uploaded. 14 September 2024 12:04 CEST Update https://www.mdpi.com/2673-6357/5/3/25/xml
article pdf uploaded. 14 September 2024 12:04 CEST Version of Record https://www.mdpi.com/2673-6357/5/3/25/pdf
article supplementary file uploaded. 14 September 2024 12:04 CEST - https://www.mdpi.com/2673-6357/5/3/25#supplementary
article html file updated 14 September 2024 12:07 CEST Original file https://www.mdpi.com/2673-6357/5/3/25/html
Back to TopTop